CPR Therapeutics is a medical device company developing the next-generation system for cardiopulmonary resuscitation.
CPR Therapeutics has raised $250K in total funding. The most recent round was Non-equity Assistance. The last funding was announced in June 2026.
CPR Therapeutics's investors include Auxilium-MBI Accelerator, National Science Foundation.
CPR Therapeutics is headquartered in Putney, United States.
CPR Therapeutics is a medical device company developing the next-generation system for cardiopulmonary resuscitation.
CPR Therapeutics is at the Non-equity Assistance stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CPR Therapeutics — Funding & Investors." VCBacked, June 16, 2026, https://www.vcbacked.co/company/cpr-therapeutics. Accessed August 14, 2026.
VCBacked. (2026). CPR Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/cpr-therapeutics
{{cite web |title=CPR Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/cpr-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated